There are 108 resources available
Q&A live discussion
Presenter: Ruben Martin Payo
Session: EONS13: Phase I clinical trials: What does this mean for our patients?
Resources:
Webcast
Invited Discussant LBA41 and 1019O
Presenter: Ignacio Melero
Session: Proffered Paper - Investigational immunotherapy
Resources:
Webcast
Why do we need phase I clinical trials?
Presenter: Martijn Lolkema
Session: EONS13: Phase I clinical trials: What does this mean for our patients?
Resources:
Slides
Webcast
Invited Discussant 1257O and 1258O
Presenter: Colin Lindsay
Session: Proffered Paper - NSCLC metastatic 1
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Lecia Sequist
Session: Proffered Paper - NSCLC metastatic 1
Resources:
Webcast
Invited Discussant LBA50 and 1259O
Presenter: Lecia Sequist
Session: Proffered Paper - NSCLC metastatic 1
Resources:
Webcast
Q&A and live discussion
Presenter: Lecia Sequist
Session: Proffered Paper - NSCLC metastatic 1
Resources:
Webcast
Q&A and live discussion
Presenter: Silvia Formenti
Session: Proffered Paper - Investigational immunotherapy
Resources:
Webcast
Invited Discussant 1020O and 1021O
Presenter: Maria Rescigno
Session: Proffered Paper - Investigational immunotherapy
Resources:
Slides
Webcast
LBA75 - Defining COVID-19 outcomes in thoracic cancer patients: TERAVOLT (Thoracic cancERs international coVid 19 cOLlaboraTion)
Presenter: Javier Baena Espinar
Session: Proffered Paper - SARS-CoV-2 and cancer 2
Resources:
Abstract
Slides
Webcast